Home | Publications | Research (R&D) | Clinical Trials place holder
place holder place holder

Clinical Trials


State of the Clinical Trials Industry 2007


Publication Date   May 2007
Publisher   CenterWatch Thomson
Product Type   Book
Pages   400
ISBN Number   1 930624 51 4
Product Code   CEN001
Ask a question about this product?

Price £295.00

approximately: $509 | €375

Summary


State of the Clinical Trials Industry 2007 is a comprehensive resource that examines all aspects of the global clinical trials industry and provides original CenterWatch data. Included are over 500 charts and graphs, a review of the top clinical research stories of 2006 as reported by the editorial staff of The CenterWatch Monthly; as well as drug pipeline information and updates on specific disease areas. Much of the data is based on CenterWatch's clinical research benchmarking surveys that have been conducted across global segments and represents an analysis of current sponsor and CRO practices.

In addition to hundreds of updated charts from the last edition, the 2007 edition also includes 100 brand new charts. It is an excellent resource to help you learn about the clinical trials industry, prepare business plans and marketing strategies, Identify and quantify trends and their impact on the clinical trials industry and create dynamic data-driven presentations and speeches

Who should buy this directory:

  • Biotech and pharmaceutical companies heads of research,
  • Business intelligence and market intelligence analysts for CROs, pharmaceutical and biotech companies and medical device companies
  • Competitive intelligence professionals,
  • Portfolio managers, investment analysts, and hedge funds
  • CRO executives and business development directors
  • Trial management companies
  • Investigative sites

Content


  • Topics Covered Include:
    • World wide sales (pharmaceutical, medical device, and biotech)
    • Overall R&D spending and cycle times
    • U.S. and world wide clinical research
    • Causes and costs associated with delays
    • Trial success based on company size
    • CRO market size, costs and performance
    • Site perceptions of sponsors and CROs
    • Regulatory submissions and approvals